MaxPro Medical
MaxPro Medical
Advanced monitoring systems optimized for integration with European healthcare standards and Brussels' medical infrastructure.
In Belgium, the shift towards Continuous Glucose Monitoring is accelerated by the RIZIV/INAMI reimbursement schemes. Our CGM systems are designed to meet the strict technical accuracy requirements (MARD < 10%) necessary for clinical adoption in Belgian hospitals and specialized diabetes conventions.
With Belgium's strong focus on "e-Health," our devices support seamless data sharing via API. This allows Belgian practitioners to integrate patient glucose data directly into local Electronic Health Records (EHR) systems used in UZ Leuven or CHU de Liège.
Leveraging Shenzhen's manufacturing prowess with efficient logistics to the Port of Antwerp, we provide Belgian distributors with a significant cost-to-performance advantage, ensuring a stable supply chain amidst global fluctuations.
As a senior growth director in the medical field, we recognize that "Information Gain" comes from understanding the nuances of Mean Absolute Relative Difference (MARD) and Time in Range (TIR). Our products aren't just hardware; they are diagnostic tools that provide 1,440 data points per day.
We provide localized solutions for the Belgian market, including French and Dutch language support for app interfaces and localized technical documentation. Our OEM/ODM capabilities allow Belgian brands to white-label our technology, ensuring compliance with the EU Medical Device Regulation (MDR).
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. We operate a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. Certified under ISO 13485, all our products comply with international medical regulations, ensuring reliability for the Belgian healthcare sector.
Moving beyond simple monitoring, our next-gen CGM sensors utilize AI to predict hypoglycemic events up to 30 minutes in advance, a feature highly sought after by Belgian clinical research centers.
While semi-invasive sensors are current standard, we are researching integration with wearable ecosystems (smartwatches) to improve patient compliance among the youth in Flanders and Wallonia.
In line with Belgium's "Green Deal" initiatives, we are optimizing our transmitter reuse cycles and reducing medical waste in our 15-day sensor packaging.
Explore our full range of ISO-certified continuous glucose monitoring systems available for bulk procurement in Belgium.
Partner with Shenzhen MaxPro Medical to provide high-accuracy, cost-effective CGM solutions to pharmacies, hospitals, and distributors across Belgium.
Send Inquiry Now
